SFX by Ex Libris Inc.

Title:	The Structure of the N-Terminal Domain of the Fragile X Mental Retardation Protein: A Platform for Protein-Protein Interaction
Source:	Structure [0969-2126] Ramos, Andres yr:2006

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Siomi, Mikiko C C. "Casein kinase II phosphorylates the fragile X mental retardation protein and modulates its biological properties." Molecular and cellular biology 22.24 (2002): 8438-47.
description	2.	Yun, Seong-Wook W. "Fmrp is required for the establishment of the startle response during the critical period of auditory development." Brain Research 1110.1 (2006): 159-165.
description	3.	Pozdnyakova, I. "New insights into Fragile X syndrome - Relating genotype to phenotype at the molecular level." The FEBS journal 272.3 (2005): 872-878.
description	4.	Trimmer, Hiroaki S. "Determinants of voltage-gated potassium channel surface expression and localization in Mammalian neurons." Critical reviews in biochemistry & molecular biology 39.3 (2004): 125-45.
description	5.	Swartz, Kenton J J. "Towards a structural view of gating in potassium channels." Nature reviews. Neuroscience 5.12 (2005): 905-16.
description	6.	Bezanilla, F. "The voltage-sensor structure in a voltage-gated channel." Trends in biochemical sciences 30.4 (2005): 166-8.
description	7.	Enomoto, K. "Expression analysis of a 17p terminal deletion, including YWHAE, but not PAFAH1B1, associated with normal brain structure on MRI in a young girl." American journal of medical genetics. Part A 158A.9 (2012): 2347-2352.
description	8.	Sung, Ying Ju J. "Species-specific and isoform-specific RNA binding of human and mouse fragile X mental retardation proteins." Biochemical and biophysical research communications 292.4 (2002): 1063-9.
description	9.	Willemsen, R. "NUFIP1 (nuclear FMRP interacting protein 1) is a nucleocytoplasmic shuttling protein associated with active synaptoneurosomes." Experimental cell research 289.1 (2003): 95-107.
description	10.	Blasing, L. "Hypersensitivity to sound in tinnitus patients: an analysis of a construct based on questionnaire and audiological data." International journal of audiology 49.7 (2010): 518-26.
description	11.	Kaufmann, WE E. "Genotype and molecular phenotype in fragile X syndrome." American journal of human genetics 61.4 (1997).
description	12.	Pelengaris, S. "c-MYC: more than just a matter of life and death." Nature reviews. Cancer 2.10 (2002): 764-76.
description	13.	Pozdnyakova, Irma, L. "New insights into Fragile X syndrome." The FEBS journal 272.3 (2005): 872-878.
description	14.	Greco, C M. "Neuropathology of fragile X-associated tremor ataxia syndrome (FXTAS)." Brain 129.1 (2006): 243-255.
description	15.	Hrecznyj, B. "Case study: risperidone treatment of children and adolescents with developmental disorders." Journal of the American Academy of Child and Adolescent Psychiatry 35.11 (1996): 1551-6.
description	16.	Koukoui, S. "Neuroanatomical, molecular genetic, and behavioral correlates of fragile X syndrome." Brain research reviews 53.1 (2007): 27-38.
description	17.	Choe, S. "Potassium channel structures." Nature reviews. Neuroscience 3.2 (2002): 115-121.
description	18.	Rugg, Michael D. "Event-related potentials and recognition memory." Trends in cognitive sciences 11.6 (2007): 251-257.
description	19.	Coghlan M J, M J J. "Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress." Journal of medicinal chemistry 44.11 (2001): 1627-53.
description	20.	Denman, N. "Alternative Splicing Modulates Protein Arginine Methyltransferase-Dependent Methylation of Fragile X Syndrome Mental Retardation Protein." Biochemistry 45.34: 10385-10393.